USPTF opens public comment for screening for abnormal glucose, type 2 diabetes

The US Preventive Services Task Force recently announced the opportunity for public comment for screening for abnormal glucose and type 2 diabetes mellitus to be open until Nov. 3, according to its website.

The task force is recommending screening for abnormal blood glucose and type 2 diabetes mellitus among adults who are at increased risk for diabetes, according to the draft recommendation.

According to the preface on the draft recommendation statement, the “[US Preventive Task Force (USPTF)] makes recommendations about the effectiveness of specific preventive care services for patients without related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service, and an assessment of the balance. … The USPTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision making to the specific patient or situation. Similarly, the USPTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.”

Public comment is open for the recommendation statement as well as evidence review.

For instructions and to view the reports in detail, visit the USPTF website.